Autolymphocyte therapy —I. In vivo tumour-specific adoptive cellular therapy of murine melanoma and carcinoma using ex vivo activated memory T-lymphocytes
Open Access
- 1 January 1994
- journal article
- retracted article
- Published by Elsevier in European Journal Of Cancer
- Vol. 30 (12) , 1871-1882
- https://doi.org/10.1016/0959-8049(94)00339-7
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Autolymphocyte TherapyClinical Immunology and Immunopathology, 1994
- Specific immune recognition of autologous tumor by lymphocytes infiltrating colon carcinomas: Analysis by cytokine secretionCancer Immunology, Immunotherapy, 1993
- Adoptive transfer of bryostatin 1-activated T cells provides long-term protection from tumour metastasesSurgical Oncology, 1992
- Effect of autolymphocyte therapy on survival and quality of life in patients with metastatic renal-cell carcinomaThe Lancet, 1990
- Interleukin-2-induced lymphoproliferative responsesCancer Immunology, Immunotherapy, 1990
- Use of Tumor-Infiltrating Lymphocytes and Interleukin-2 in the Immunotherapy of Patients with Metastatic MelanomaNew England Journal of Medicine, 1988
- A Progress Report on the Treatment of 157 Patients with Advanced Cancer Using Lymphokine-Activated Killer Cells and Interleukin-2 or High-Dose Interleukin-2 AloneNew England Journal of Medicine, 1987
- A New Approach to the Adoptive Immunotherapy of Cancer with Tumor-Infiltrating LymphocytesScience, 1986
- Observations on the Systemic Administration of Autologous Lymphokine-Activated Killer Cells and Recombinant Interleukin-2 to Patients with Metastatic CancerNew England Journal of Medicine, 1985
- ADOPTIVE IMMUNIZATION AGAINST AN ESTABLISHED TUMOR WITH CYTOLYTIC VERSUS MEMORY T CELLSTransplantation, 1984